FDA Class II Drug Recall: TOBRADEX Ophthalmic Ointment, Temperature Abuse
McKesson Medical-Surgical is recalling TOBRADEX ophthalmic ointment nationwide due to cGMP deviations involving temperature abuse. Product distributed between June 1 and September 30, 2021 may be affected.
- Product
- TOBRADEX — TOBRADEX (TOBRAMYCIN AND DEXAMETHASONE)
- Category
- Drug
- Distribution
- Distributed nationwide